Your browser doesn't support javascript.
loading
Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials.
Arnone, Danilo; Omar, Omar; Arora, Teresa; Östlundh, Linda; Ramaraj, Reshma; Javaid, Syed; Govender, Romona Devi; Ali, Bassam R; Patrinos, George P; Young, Allan H; Stip, Emmanuel.
Afiliación
  • Arnone D; Department of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; Centre for Affective Disorders, Psychological Medicine, Institute of Psychiatry, King's College London, London, United Kingdom. Electronic address: danilo.arnone@kcl.ac.u
  • Omar O; University of Birmingham, Birmingham Clinical Trials Unit, Birmingham, United Kingdom.
  • Arora T; Zayed University, College of Natural & Health Sciences, Abu Dhabi, United Arab Emirates.
  • Östlundh L; Örebro University, Örebro, Sweden.
  • Ramaraj R; Department of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Javaid S; Department of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Govender RD; Department of Family Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Ali BR; Department of Genetics and Genomics, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Patrinos GP; Department of Genetics and Genomics, United Arab Emirates University, Al Ain, United Arab Emirates; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Young AH; Centre for Affective Disorders, Psychological Medicine, Institute of Psychiatry, King's College London, London, United Kingdom; South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Stip E; Department of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; Université de Montreal, Institut Universitaire en Santé Mentale de Montreal, Montreal, Canada.
Neurosci Biobehav Rev ; 144: 104965, 2023 01.
Article en En | MEDLINE | ID: mdl-36463971
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Neurosci Biobehav Rev Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Neurosci Biobehav Rev Año: 2023 Tipo del documento: Article